Emerging combination immunotherapy strategies for breast cancer: dual immune checkpoint modulation, antibody–drug conjugates and bispecific antibodies-Reference-Cited by-同舟云学术

Emerging combination immunotherapy strategies for breast cancer: dual immune checkpoint modulation, antibody–drug conjugates and bispecific antibodies

Published:2021-10-30 Issue:2 Volume:191 Page:291-302
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Torres Evanthia T. Roussos,Emens Leisha A.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s10549-021-06423-0.pdf

Reference68 articles.

1. Chen DS, Mellman I (2013) Oncology meets immunology: the cancer-immunity cycle. Immunity 39(1):1–10. https://doi.org/10.1016/j.immuni.2013.07.012

2. Topper MJ, Vaz M, Marrone KA, Brahmer JA, Baylin SB (2020) The emerging role of epigenetic therapeutics in immuno-oncology. Nat Rev Clin Oncol 17(2):75–90. https://doi.org/10.1038/s41571-019-0266-5

3. Jenkins RW, Barbie DA, Flaherty KT (2018) Mechanisms of resistance to immune checkpoint inhibitors. Br J Cancer 118(1):9–16. https://doi.org/10.1038/bjc.2017.434

4. Emens LA (2018) Breast cancer immunotherapy: facts and hopes. Clin Cancer Res 24(3):511–520. https://doi.org/10.1158/1078-0432.CCR-16-3001

5. Schmid P, Adams S, Rugo HS, Schneeweiss A, Barrios CH, Iwata H, Dieras V, Hegg R, Im S-A, Wright GS, Henschel V, Molinero L, Chui SY, Funke R, Husain A, Winer EP, Loi S, Emens LA, IMpassion130 Trial Investigators (2018) Atezolizumab and nab-paclitaxel in advanced triple negative breast cancer. N Engl J Med 379(22):2108–2121. https://doi.org/10.1056/NEJM0a1809615

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic risk model under the immune-associated long chain non-coding ribonucleic acid and its application in survival prognosis assessment of patients with breast cancer;Scientific Reports;2024-08-15

2. Antibody-Drug Conjugates to Promote Immune Surveillance: Lessons Learned from Breast Cancer;Biomedicines;2024-07-05

3. Breast Cancer Treatment Strategies Targeting the Tumor Microenvironment: How to Convert “Cold” Tumors to “Hot” Tumors;International Journal of Molecular Sciences;2024-06-29

4. CRISPR/Cas9-mediated knockout strategies for enhancing immunotherapy in breast cancer;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-06-22

5. Antibody-Drug Conjugates: A promising breakthrough in cancer therapy;International Journal of Pharmaceutics;2024-06